| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.3M | +191.8% |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $14.3M | +7.1% |
| Operating Income | -$23.7M | -2.6% |
| Pre-tax Income | -$40.8M | +69.7% |
| Income Tax | $0 | — |
| Net Income | -$40.8M | +69.7% |
| EPS (Basic) | -$10.45 | +71.5% |
| EPS (Diluted) | -$10.45 | +71.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.0M | +491.6% |
| Accounts Receivable | $379K | +58.8% |
| Inventory | $0 | -100.0% |
| Current Assets | $9.3M | +114.2% |
| Total Assets | $42.6M | +87.8% |
| Current Liabilities | $35.4M | +187.6% |
| Long-term Debt | $21.5M | -25.7% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.0M | +4.9% |
| Capital Expenditures | $962K | +91.7% |
| Investing Cash Flow | -$5.3M | -3058.5% |
| Financing Cash Flow | $34.7M | +41.7% |
| Free Cash Flow | -$24.0M | +3.0% |
| $35.6M |
| -17.4% |
| Stockholders' Equity | $7.0M | +134.4% |